journal
Journals Gastroenterology & Hepatology

Gastroenterology & Hepatology

https://read.qxmd.com/read/38445188/long-term-clinical-endoscopic-and-symptomatic-outcomes-of-treatment-with-ozanimod-interim-analysis-of-the-true-north-open-label-extension-study
#21
JOURNAL ARTICLE
Long-Term Clinical, Endoscopic, and Symptomatic Outcomes of Treatment With Ozanimod: Interim Analysis of the True North Open-Label Extension Study.
(no author information available yet)
No abstract text is available yet for this article.
38445188
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445187/risankizumab-induction-therapy-in-patients-with-moderately-to-severely-active-ulcerative-colitis-efficacy-and-safety-in-the-randomized-phase-3-inspire-study
#22
JOURNAL ARTICLE
Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study.
(no author information available yet)
No abstract text is available yet for this article.
38445187
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445186/two-year-efficacy-and-safety-of-mirikizumab-following-104-weeks-of-continuous-treatment-interim-results-from-the-lucent-3-open-label-extension-study-ulcerative-colitis
#23
JOURNAL ARTICLE
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment: Interim Results From the LUCENT-3 Open-Label Extension Study (Ulcerative Colitis).
(no author information available yet)
No abstract text is available yet for this article.
38445186
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445185/highlights-in-ulcerative-colitis-from-the-american-college-of-gastroenterology-2023-annual-scientific-meeting-commentary
#24
JOURNAL ARTICLE
Highlights in Ulcerative Colitis From the American College of Gastroenterology 2023 Annual Scientific Meeting: Commentary.
Gary R Lichtenstein
No abstract text is available yet for this article.
38445185
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445184/upadacitinib-safety-and-time-to-relapse-analysis-of-phase-3-maintenance-studies-u-achieve-and-u-endure-in-patients-with-moderately-to-severely-active-ulcerative-colitis
#25
JOURNAL ARTICLE
Upadacitinib Safety and Time to Relapse: Analysis of Phase 3 Maintenance Studies, U-ACHIEVE and U-ENDURE, in Patients With Moderately to Severely Active Ulcerative Colitis.
(no author information available yet)
No abstract text is available yet for this article.
38445184
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445183/symptomatic-improvement-observed-within-2-days-of-etrasimod-induction-therapy-results-from-elevate-uc-52-and-elevate-uc-12-studies-in-patients-with-ulcerative-colitis
#26
JOURNAL ARTICLE
Symptomatic Improvement Observed Within 2 Days of Etrasimod Induction Therapy: Results From ELEVATE UC 52 and ELEVATE UC 12 Studies in Patients With Ulcerative Colitis.
(no author information available yet)
No abstract text is available yet for this article.
38445183
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445182/comparative-effectiveness-of-upadacitinib-vs-ustekinumab-for-ulcerative-colitis-at-8-16-weeks-a-multicenter-retrospective-cohort-study
#27
JOURNAL ARTICLE
Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis at 8-16 Weeks: A Multicenter Retrospective Cohort Study.
(no author information available yet)
No abstract text is available yet for this article.
38445182
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38445181/early-symptomatic-improvement-with-guselkumab-induction-treatment-in-moderately-to-severely-active-ulcerative-colitis-results-from-the-phase-3-quasar-study
#28
JOURNAL ARTICLE
Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Study.
(no author information available yet)
No abstract text is available yet for this article.
38445181
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444690/improving-outcomes-in-hepatorenal-syndrome-acute-kidney-injury-with-early-diagnoses-and-implementation-of-approved-treatment-regimens
#29
JOURNAL ARTICLE
Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens.
Nikolaos T Pyrsopoulos, David Bernstein, Marcelo Kugelmas, Emily J Owen, K Rajender Reddy, Nancy Reau, Sammy Saab, Hani M Wadei
Decompensated cirrhosis, defined by the overt manifestations of liver failure and portal hypertension (eg, ascites, hepatic encephalopathy, variceal bleeding), is the inflection point associated with increased morbidity and mortality in chronic liver disease. Acute kidney injury in the setting of cirrhosis (hepatorenal syndrome-acute kidney injury [HRS-AKI]) is a severe and often fatal complication. The goals of treatment of HRS-AKI are to reverse renal failure and prolong survival in these critically ill patients or perhaps to allow the transplant team to complete the pretransplant evaluation and bridge the patient to transplant...
38444690
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444458/ustekinumab-reintroduction-week-16-results-and-baseline-response-analysis-from-the-power-study-in-patients-with-crohn-s-disease
#30
JOURNAL ARTICLE
Ustekinumab Reintroduction: Week 16 Results and Baseline Response Analysis From the POWER Study in Patients With Crohn's Disease.
(no author information available yet)
No abstract text is available yet for this article.
38444458
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444457/highlights-in-crohn-s-disease-from-the-american-college-of-gastroenterology-acg-2023-annual-scientific-meeting-commentary
#31
JOURNAL ARTICLE
Highlights in Crohn's Disease From the American College of Gastroenterology (ACG) 2023 Annual Scientific Meeting: Commentary.
David T Rubin
No abstract text is available yet for this article.
38444457
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444456/safety-and-efficacy-of-risankizumab-in-crohn-s-disease-prospective-real-world-experience-and-systematic-literature-review
#32
JOURNAL ARTICLE
Safety and Efficacy of Risankizumab in Crohn's Disease: Prospective Real-World Experience and Systematic Literature Review.
(no author information available yet)
No abstract text is available yet for this article.
38444456
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444455/analysis-of-upadacitinib-in-ibd-evaluating-safety-and-efficacy-across-phase-3-trials-in-patients-with-crohn-s-disease-or-ulcerative-colitis
#33
JOURNAL ARTICLE
Analysis of Upadacitinib in IBD: Evaluating Safety and Efficacy Across Phase 3 Trials in Patients With Crohn's Disease or Ulcerative Colitis.
(no author information available yet)
No abstract text is available yet for this article.
38444455
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444454/insights-on-filgotinib-in-crohn-s-disease-from-the-diversity1-and-selection-studies
#34
JOURNAL ARTICLE
Insights on Filgotinib in Crohn's Disease From the DIVERSITY1 and SELECTION Studies.
(no author information available yet)
No abstract text is available yet for this article.
38444454
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444453/efficacy-and-safety-of-guselkumab-in-crohn-s-disease-results-from-the-galaxi-1-study
#35
JOURNAL ARTICLE
Efficacy and Safety of Guselkumab in Crohn's Disease: Results From the GALAXI 1 Study.
(no author information available yet)
No abstract text is available yet for this article.
38444453
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38444452/real-world-clinical-effectiveness-and-safety-of-vedolizumab-and-ustekinumab-in-bio-naive-patients-with-complex-or-noncomplex-crohn-s-disease-results-from-the-evolve-expansion-study
#36
JOURNAL ARTICLE
Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-naive Patients With Complex or Noncomplex Crohn's Disease: Results From the EVOLVE Expansion Study.
(no author information available yet)
No abstract text is available yet for this article.
38444452
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38404420/efforts-to-support-effective-teaching-in-endoscopy
#37
JOURNAL ARTICLE
Efforts to Support Effective Teaching in Endoscopy.
Jonathan Cohen
No abstract text is available yet for this article.
38404420
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38404419/preventative-hepatology-and-the-reduction-of-all-cause-mortality-in-liver-disease
#38
JOURNAL ARTICLE
Preventative Hepatology and the Reduction of All-Cause Mortality in Liver Disease.
Jennifer C Price
No abstract text is available yet for this article.
38404419
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38404418/endoscopic-approaches-to-crohn-s-disease-strictures
#39
JOURNAL ARTICLE
Endoscopic Approaches to Crohn's Disease Strictures.
Gursimran Singh Kochhar
No abstract text is available yet for this article.
38404418
December 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38404417/the-importance-of-making-an-accurate-diagnosis-for-hepatic-encephalopathy
#40
JOURNAL ARTICLE
The Importance of Making an Accurate Diagnosis for Hepatic Encephalopathy.
Nancy S Reau
No abstract text is available yet for this article.
38404417
December 2023: Gastroenterology & Hepatology
next page »
journal
journal
41233
2
3
Make the most of Read.
Download the mobile app.
Fetch more papers »
Fetching more papers... Fetching...

All material on this website is protected by copyright, Copyright © 1994-2024 1994-{new Date().getFullYear()} by WebMD LLC.

By using this service, you agree to our terms of use and privacy policy.

Do Not Sell My Personal Information  Your Privacy Choices

Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

╳

We want to hear from doctors like you!

Take a second to answer a survey question.

╳